Answers are grounded in this paper and cite their sources.
Oncogene-induced senescence (OIS) is an irreversible form of cell cycle arrest that can be elicited by overexpression of oncogenes such as RasV12 and requires activation of the Arf-p53 and RB tumor suppressor pathways. Increasing evidence implicates senescence as a bona fide tumor suppression mechanism in vivo. We recently discovered that the bZIP transcription factor C/EBPbeta, a downstream target of Ras signaling, is an essential component of RasV12-mediated senescence in mouse embryo fibroblasts (MEFs). C/EBPbeta induces cell cycle arrest through a mechanism requiring RB:E2F repressor complexes and negatively regulates several E2F target genes. Although C/EBPbeta has tumor suppressor-like activity in MEFs, other observations point to critical pro-oncogenic functions for C/EBPbeta in certain cancers. Here we review the evidence for positive and negative cell cycle regulation by C/EBPbeta and discuss possible mechanisms by which this transcription factor could participate in both cellular senescence and oncogenic transformation.
No takes yet. Share an insight, caveat, or question.
Sebastian et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: